TLIS - Talis Biomedical Corp
IEX Last Trade
4.41
4.410 100.000%
Share volume: 0
Last Updated: Fri 30 Aug 2024 08:00:00 PM CEST
Surgical and Medical Instrument Manufacturing :
-0.06%
PREVIOUS CLOSE
CHG
CHG%
N/A
0.00
0.00%
View ratios
Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
---|---|---|---|---|---|---|---|---|---|
Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
Report Date | 2022-08-02 | 2022-11-03 | 2023-03-22 | 2023-05-11 | 2023-08-10 | 2023-11-14 | 2024-03-28 | 2024-05-08 | |
Total revenue | 572.000 K | 796.000 K | 257.000 K | 1.218 M | 581.000 K | 140.000 K | 195.000 K | 73.000 K | |
Cost of revenue | 1.302 M | 1.236 M | 2.332 M | 20.000 K | 7.000 K | 6.000 K | 8.000 K | 6.000 K | |
Gross profit | -730.000 K | -440.000 K | -2.075 M | 1.198 M | 574.000 K | 134.000 K | 187.000 K | 67.000 K | |
39.73% | -371.59% | 157.73% | -52.09% | -76.66% | 39.55% | -64.17% | |||
Operating expenses | 26.543 M | 26.346 M | 26.038 M | 20.195 M | 16.965 M | 17.105 M | 14.643 M | 14.184 M | |
Selling general and admin | 9.178 M | 8.825 M | 10.796 M | 6.399 M | 6.410 M | 8.803 M | 6.602 M | 11.651 M | |
Research and development | 17.365 M | 17.521 M | 15.242 M | 13.796 M | 10.555 M | 8.302 M | 8.041 M | 2.533 M | |
Total expenses | 27.845 M | 27.582 M | 28.370 M | 20.215 M | 16.972 M | 17.111 M | 14.651 M | 14.190 M | |
-0.94% | 2.86% | -28.75% | -16.04% | 0.82% | -14.38% | -3.15% | |||
Operating income | -27.273 M | -26.786 M | -28.113 M | -18.997 M | -16.391 M | -16.971 M | -14.456 M | -14.117 M | |
Ebit | -27.273 M | -26.786 M | -28.113 M | -18.997 M | -16.391 M | -16.971 M | -14.456 M | -14.117 M | |
Pretax income | -27.011 M | -26.021 M | -26.929 M | -17.831 M | -15.034 M | -15.682 M | -13.460 M | -13.035 M | |
-3.67% | 3.49% | -33.79% | -15.69% | 4.31% | -14.17% | -3.16% | |||
Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
Net income basic | -27.011 M | -26.021 M | -26.929 M | -17.831 M | -15.034 M | -15.682 M | -13.460 M | -13.035 M | |
3.67% | -3.49% | 33.79% | 15.69% | -4.31% | 14.17% | 3.16% | |||
Net income | -27.011 M | -26.021 M | -26.929 M | -17.831 M | -15.034 M | -15.682 M | -13.460 M | -13.035 M | |
3.67% | -3.49% | 33.79% | 15.69% | -4.31% | 14.17% | 3.16% |